4//SEC Filing
HEALTH NET INC 4
Accession 0001179110-14-014485
CIK 0000916085operating
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 7:58 PM ET
Size
25.2 KB
Accession
0001179110-14-014485
Insider Transaction Report
Form 4
Bouchard Angelee F.
SVP, General Counsel,Secretar
Transactions
- Sale
Common Stock
2014-09-22$46.61/sh−36,000$1,677,960→ 34,250 total - Sale
Common Stock
2014-09-23$46.13/sh−4,250$196,053→ 34,250 total - Exercise/Conversion
Common Stock
2014-09-22$30.73/sh+36,000$1,106,280→ 70,250 total - Exercise/Conversion
Common Stock
2014-09-23$29.20/sh+4,250$124,100→ 38,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-22−36,000→ 0 totalExercise: $30.73Exp: 2018-02-18→ Common Stock (36,000 underlying) - Exercise/Conversion
Common Stock
2014-09-23$23.24/sh+35,000$813,400→ 69,250 total - Sale
Common Stock
2014-09-22$46.42/sh−10,704$496,880→ 34,250 total - Sale
Common Stock
2014-09-23$46.08/sh−35,000$1,612,800→ 34,250 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-23−4,250→ 0 totalExercise: $29.20Exp: 2015-02-24→ Common Stock (4,250 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-23−35,000→ 0 totalExercise: $23.24From: 2012-12-14Exp: 2016-12-14→ Common Stock (35,000 underlying)
Holdings
- 15,000(indirect: By Trust)
Common Stock
Footnotes (11)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.37 to $46.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Act").
- [F10]The 2011 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of February 18, 2011, the grant date.
- [F11]The 2005 Grant became exercisable in 25% increments on each of the first, second, third and fourth anniversaries of February 24, 2005, the grant date.
- [F2]Includes 13,205 shares previously held through the Bouchard Family Revocable Trust, of which the Reporting Person is a trustee and beneficiary, which were transferred to a separate account held directly by the Reporting Person. Such transfer represented a change in the form of beneficial ownership only without a change in the Reporting Person's pecuniary interest in such shares.
- [F3]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 18, 2011 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2011 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2011 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.41 to $47.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F5]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 24, 2005 under the Issuer's 1998 Stock Option Plan, as amended (the "2005 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2005 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.90 to $46.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F7]Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on December 14, 2009 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2009 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.78 to $46.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- [F9]Excludes 13,205 shares previously held through the Bouchard Family Revocable Trust, of which the Reporting Person is a trustee and beneficiary, which were transferred to a separate account held directly by the Reporting Person. Such transfer represented a change in the form of beneficial ownership only without a change in the Reporting Person's pecuniary interest in such shares.
Documents
Issuer
HEALTH NET INC
CIK 0000916085
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000916085
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 7:58 PM ET
- Size
- 25.2 KB